Probenecid shows activity against respiratory syncytial virus - News-Medical.Net

A new study describes the antiviral activity of the approved drug probenecid against respiratory syncytial virus.

Among the most common viruses causing viral respiratory disease is the respiratory syncytial virus (RSV), with the greatest burden of disease in infants and young children. Many researchers have tri… [+4691 chars]

full article...